Tumor immunotherapy based on tumor-derived heat shock proteins (Review)
Heat shock proteins (HSPs), the most important type of molecular chaperone, are expressed in all eukaryotic cells and have multiple functions, including the folding and unfolding of other proteins and peptides, the transport of proteins and peptides and the support of antigen presentation processes....
Saved in:
| Published in | Oncology letters Vol. 6; no. 6; pp. 1543 - 1549 |
|---|---|
| Main Authors | , |
| Format | Journal Article |
| Language | English |
| Published |
Greece
D.A. Spandidos
01.12.2013
Spandidos Publications UK Ltd |
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | Heat shock proteins (HSPs), the most important type of molecular chaperone, are expressed in all eukaryotic cells and have multiple functions, including the folding and unfolding of other proteins and peptides, the transport of proteins and peptides and the support of antigen presentation processes. Due to these important properties, the use of HSPs has been explored as a promising tumor immunotherapy strategy. It has been previously demonstrated that HSP peptide complex (HSP.PC) derived from tumors is the immunogenic entity that elicits powerful antitumor immune responses. Previous animal studies and phase III clinical trials have demonstrated the efficacy, safety and feasibility of HSP-based tumor vaccines. However, the limitations are also apparent and specific alternatives have been developed. The present review focused on the history of HSP-based immunotherapy, the mechanism of its immunogenicity and the previous efforts to promote the efficacy. The current review may be useful for antitumor studies based on the tumor-derived HSPs. |
|---|---|
| AbstractList | Heat shock proteins (HSPs), the most important type of molecular chaperone, are expressed in all eukaryotic cells and have multiple functions, including the folding and unfolding of other proteins and peptides, the transport of proteins and peptides and the support of antigen presentation processes. Due to these important properties, the use of HSPs has been explored as a promising tumor immunotherapy strategy. It has been previously demonstrated that HSP peptide complex (HSP.PC) derived from tumors is the immunogenic entity that elicits powerful antitumor immune responses. Previous animal studies and phase III clinical trials have demonstrated the efficacy, safety and feasibility of HSP-based tumor vaccines. However, the limitations are also apparent and specific alternatives have been developed. The present review focused on the history of HSP-based immunotherapy, the mechanism of its immunogenicity and the previous efforts to promote the efficacy. The current review may be useful for antitumor studies based on the tumor-derived HSPs. Heat shock proteins (HSPs), the most important type of molecular chaperone, are expressed in all eukaryotic cells and have multiple functions, including the folding and unfolding of other proteins and peptides, the transport of proteins and peptides and the support of antigen presentation processes. Due to these important properties, the use of HSPs has been explored as a promising tumor immunotherapy strategy. It has been previously demonstrated that HSP peptide complex (HSP.PC) derived from tumors is the immunogenic entity that elicits powerful antitumor immune responses. Previous animal studies and phase III clinical trials have demonstrated the efficacy, safety and feasibility of HSP-based tumor vaccines. However, the limitations are also apparent and specific alternatives have been developed. The present review focused on the history of HSP-based immunotherapy, the mechanism of its immunogenicity and the previous efforts to promote the efficacy. The current review may be useful for antitumor studies based on the tumor-derived HSPs.Heat shock proteins (HSPs), the most important type of molecular chaperone, are expressed in all eukaryotic cells and have multiple functions, including the folding and unfolding of other proteins and peptides, the transport of proteins and peptides and the support of antigen presentation processes. Due to these important properties, the use of HSPs has been explored as a promising tumor immunotherapy strategy. It has been previously demonstrated that HSP peptide complex (HSP.PC) derived from tumors is the immunogenic entity that elicits powerful antitumor immune responses. Previous animal studies and phase III clinical trials have demonstrated the efficacy, safety and feasibility of HSP-based tumor vaccines. However, the limitations are also apparent and specific alternatives have been developed. The present review focused on the history of HSP-based immunotherapy, the mechanism of its immunogenicity and the previous efforts to promote the efficacy. The current review may be useful for antitumor studies based on the tumor-derived HSPs. |
| Author | ZHANG, YUNFEI ZHENG, LIANHE |
| Author_xml | – sequence: 1 givenname: YUNFEI surname: ZHANG fullname: ZHANG, YUNFEI – sequence: 2 givenname: LIANHE surname: ZHENG fullname: ZHENG, LIANHE |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/24260044$$D View this record in MEDLINE/PubMed |
| BookMark | eNp1kd9rFDEQx4O02Fr75rMsCFLBPfNrs9mXghSthUJB6nPIJnNe6m6yJtmT_vdmuXpqoSGQIfOZLzPzfYEOfPCA0CuCV0x29EMYVhQTtiKCiGfomLQdrQmW9GAft_wInaZ0h8tpBJFSPEdHlFOBMefH6PJ2HkOs3DjOPuQNRD3dV71OYKvgq7wkawvRbcvHBnSu0iaYH9UUQwbnU3X2FbYOfr17iQ7Xekhw-vCeoG-fP91efKmvby6vLj5e16bBXa6BUSEFNlz3hHQNt0IY2XDZtbbna0YNk1qutWgpkWCYsQR021jGWduDhZ6doPOd7jT3I1gDPkc9qCm6Ucd7FbRT_2e826jvYauYZJwQUQTOHgRi-DlDymp0ycAwaA9hTopIKppWctEW9M0j9C7M0ZfxFOnKIIVpukK9_rejfSt_dlyA9zvAxJBShPUeIVgtLqowqMVFtbhYcPoINy7r7MIyjxueKnq7K0qT9tbZkP6uZKixWC5pOGO_AYQRrAo |
| CitedBy_id | crossref_primary_10_1016_j_nano_2018_09_004 crossref_primary_10_32604_or_2023_027942 crossref_primary_10_1002_wnan_1870 crossref_primary_10_1016_j_advms_2023_10_005 crossref_primary_10_1186_s41231_024_00174_y crossref_primary_10_1016_j_micpath_2017_08_027 crossref_primary_10_1080_02656736_2020_1746413 crossref_primary_10_1016_j_bioorg_2023_106643 crossref_primary_10_3390_ijms23147792 crossref_primary_10_1371_journal_pone_0196469 crossref_primary_10_3390_ijms20184588 crossref_primary_10_1371_journal_pone_0126075 crossref_primary_10_3892_or_2015_3934 crossref_primary_10_1124_jpet_123_001673 crossref_primary_10_1517_14712598_2014_902928 crossref_primary_10_1016_j_jconrel_2018_09_009 |
| Cites_doi | 10.1007/s00262-007-0359-3 10.1007/s00262-002-0263-9 10.1007/BF00188611 10.1146/annurev.ge.22.120188.003215 10.1146/annurev.cb.09.110193.003125 10.1002/1521-4141(200002)30:2<594::AID-IMMU594>3.0.CO;2-1 10.1007/978-1-62703-218-6_17 10.4049/jimmunol.0902255 10.1016/S0092-8674(00)80928-9 10.4049/jimmunol.171.7.3467 10.1038/77835 10.1038/77770 10.1038/nri749 10.1038/355033a0 10.1200/JCO.2007.11.9941 10.1126/science.272.5268.1606 10.1002/1521-4141(2000)30:8<2211::AID-IMMU2211>3.0.CO;2-0 10.1016/S0952-7915(98)80039-3 10.1084/jem.178.4.1391 10.1046/j.1523-1747.2000.00038.x 10.2337/diabetes.50.6.1274 10.1016/S1074-7613(01)00111-X 10.1111/j.1365-2249.2007.03323.x 10.1034/j.1600-0854.2001.21003.x 10.1016/S0140-6736(08)60697-2 10.1073/pnas.83.10.3121 10.4049/jimmunol.152.11.5398 10.1073/pnas.84.11.3807 10.1586/14760584.2.3.369 10.1146/annurev.ge.27.120193.002253 10.1016/S0092-8674(00)80806-5 10.1158/1078-0432.CCR-05-0250 10.1084/jem.186.8.1315 10.3892/or.2012.2051 10.1084/jem.20020436 10.1016/0092-8674(94)90416-2 10.1196/annals.1391.030 10.1073/pnas.83.10.3407 10.1146/annurev.immunol.20.100301.064801 10.1002/ijc.2910330321 10.1016/S1074-7613(00)80570-1 10.1007/s00262-005-0084-8 10.1038/80795 10.1080/02656730210166140 10.1182/blood.V98.6.1852 10.1093/intimm/12.11.1539 10.1002/1097-0215(20001015)88:2<232::AID-IJC14>3.0.CO;2-8 10.1089/104303403765255129 10.1084/jem.191.11.1965 10.1126/science.7545313 10.4049/jimmunol.165.11.6029 10.1002/j.1460-2075.1993.tb05983.x 10.1111/j.1749-6632.1962.tb26446.x 10.1189/jlb.0306167 10.1126/science.278.5335.117 10.4049/jimmunol.168.6.2997 10.4049/jimmunol.177.9.5946 10.1007/s00262-003-0481-9 10.1093/intimm/13.9.1121 |
| ContentType | Journal Article |
| Copyright | Copyright © 2013, Spandidos Publications Copyright Spandidos Publications UK Ltd. 2013 Copyright © 2013, Spandidos Publications 2013 |
| Copyright_xml | – notice: Copyright © 2013, Spandidos Publications – notice: Copyright Spandidos Publications UK Ltd. 2013 – notice: Copyright © 2013, Spandidos Publications 2013 |
| DBID | AAYXX CITATION NPM 3V. 7X7 7XB 8FI 8FJ 8FK ABUWG AFKRA AN0 BENPR CCPQU FYUFA GHDGH K9. M0S PHGZM PHGZT PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 5PM |
| DOI | 10.3892/ol.2013.1616 |
| DatabaseName | CrossRef PubMed ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland British Nursing Database ProQuest Central ProQuest One Community College Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) ProQuest Health & Medical Collection ProQuest Central Premium ProQuest One Academic ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) |
| DatabaseTitle | CrossRef PubMed ProQuest One Academic Middle East (New) ProQuest One Academic Eastern Edition ProQuest Health & Medical Complete (Alumni) British Nursing Index with Full Text ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest Hospital Collection ProQuest One Health & Nursing Health Research Premium Collection (Alumni) ProQuest Central China ProQuest Hospital Collection (Alumni) ProQuest Central ProQuest Health & Medical Complete Health Research Premium Collection ProQuest One Academic UKI Edition Health and Medicine Complete (Alumni Edition) ProQuest Central (New) ProQuest One Academic ProQuest Central (Alumni) ProQuest One Academic (New) MEDLINE - Academic |
| DatabaseTitleList | PubMed MEDLINE - Academic ProQuest One Academic Middle East (New) |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X7 name: Health & Medical Collection url: https://search.proquest.com/healthcomplete sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1792-1082 |
| EndPage | 1549 |
| ExternalDocumentID | PMC3834116 24260044 10_3892_ol_2013_1616 ol-06-06-1543 |
| Genre | Journal Article |
| GroupedDBID | - 0R 3V. 53G 7X7 8FI 8FJ AAKDD AAPBV AASXA ABDBF ABPTK ABUWG ACGFS ADBBV AENEX AFKRA AHMBA ALMA_UNASSIGNED_HOLDINGS AN0 BBAFP BENPR BNQBC BPHCQ BVXVI C45 EBD EBS EJD ESX F5P FYUFA H13 HUR HZ IAO IHR IHW ITC O9- OK1 OVD PQEST PQQKQ PQUKI PRINS PROAC RIG W2D --- 0R~ AAYXX ABJNI ACUHS ALIPV CCPQU CITATION HMCUK HZ~ IPNFZ PHGZM PHGZT RPM TEORI UKHRP NPM 7XB 8FK K9. PKEHL PPXIY 7X8 5PM |
| ID | FETCH-LOGICAL-c509t-e326860c4ab11954d66c854897db4f32c38a8fa67218ec3cd1ea75d3437bedeb3 |
| IEDL.DBID | 7X7 |
| ISSN | 1792-1074 |
| IngestDate | Thu Aug 21 17:55:41 EDT 2025 Fri Jul 11 14:21:13 EDT 2025 Fri Jul 25 08:21:50 EDT 2025 Thu Jan 02 22:12:38 EST 2025 Thu Apr 24 22:55:36 EDT 2025 Tue Jul 01 01:12:03 EDT 2025 Tue Jan 05 23:28:40 EST 2021 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 6 |
| Keywords | molecular chaperone vaccine heat shock proteins immunotherapy |
| Language | English |
| License | This is an open-access article licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. The article may be redistributed, reproduced, and reused for non-commercial purposes, provided the original source is properly cited. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c509t-e326860c4ab11954d66c854897db4f32c38a8fa67218ec3cd1ea75d3437bedeb3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
| OpenAccessLink | https://pubmed.ncbi.nlm.nih.gov/PMC3834116 |
| PMID | 24260044 |
| PQID | 1932646759 |
| PQPubID | 2044954 |
| PageCount | 7 |
| ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_3834116 proquest_miscellaneous_1826578467 proquest_journals_1932646759 pubmed_primary_24260044 crossref_primary_10_3892_ol_2013_1616 crossref_citationtrail_10_3892_ol_2013_1616 spandidos_primary_ol-06-06-1543 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2013-12-01 |
| PublicationDateYYYYMMDD | 2013-12-01 |
| PublicationDate_xml | – month: 12 year: 2013 text: 2013-12-01 day: 01 |
| PublicationDecade | 2010 |
| PublicationPlace | Greece |
| PublicationPlace_xml | – name: Greece – name: Athens |
| PublicationTitle | Oncology letters |
| PublicationTitleAlternate | Oncol Lett |
| PublicationYear | 2013 |
| Publisher | D.A. Spandidos Spandidos Publications UK Ltd |
| Publisher_xml | – name: D.A. Spandidos – name: Spandidos Publications UK Ltd |
| References | Ciupitu, Petersson, Kono, Charo, Kiessling (b61-ol-06-06-1543) 2002; 51 Baker-LePain, Sarzotti, Fields, Li, Nicchitta (b62-ol-06-06-1543) 2002; 196 Rivoltini, Castelli, Carrabba (b44-ol-06-06-1543) 2003; 171 Basu, Binder, Suto, Anderson, Srivastava (b55-ol-06-06-1543) 2000; 12 Milani, Noessner, Ghose (b11-ol-06-06-1543) 2002; 18 Binder, Anderson, Basu, Srivastava (b60-ol-06-06-1543) 2000; 165 Castelli, Ciupitu, Rini (b7-ol-06-06-1543) 2001; 61 Shinagawa, Yamazaki, Tamura (b18-ol-06-06-1543) 2008; 57 Li, Srivastava (b9-ol-06-06-1543) 1993; 12 Srivastava, Maki (b39-ol-06-06-1543) 1991; 167 Sato, Torimoto, Tamura (b19-ol-06-06-1543) 2001; 98 Bukau, Horwich (b41-ol-06-06-1543) 1998; 92 Vanaja, Grossmann, Celis, Young (b13-ol-06-06-1543) 2000; 60 Schmitt, Gehrmann, Brunet, Multhoff, Garrido (b24-ol-06-06-1543) 2007; 81 Kojima, Yamazaki, Tamura (b21-ol-06-06-1543) 2003; 14 Srivastava (b25-ol-06-06-1543) 2002; 20 Srivastava, Das (b29-ol-06-06-1543) 1984; 33 Srivastava, Chen, Old (b38-ol-06-06-1543) 1987; 84 Sherman, Multhoff (b10-ol-06-06-1543) 2007; 1113 Panjwani, Popova, Srivastava (b58-ol-06-06-1543) 2002; 168 Castelli, Rivoltini, Rini (b28-ol-06-06-1543) 2004; 53 Li, Zeng, Chen (b63-ol-06-06-1543) 2007; 148 Abiru, Maniatis, Yu (b48-ol-06-06-1543) 2001; 50 Ritossa (b1-ol-06-06-1543) 1962; 37 Testori, Richards, Whitman (b16-ol-06-06-1543) 2008; 26 Martin, Lappin, Kohler (b47-ol-06-06-1543) 2000; 115 Murshid, Gong, Calderwood (b65-ol-06-06-1543) 2013; 960 Hoos, Levey (b30-ol-06-06-1543) 2003; 2 Srivastava, Udono, Blachere, Li (b49-ol-06-06-1543) 1994; 39 Bukau, Deuerling, Pfund, Craig (b6-ol-06-06-1543) 2000; 101 Pilla, Patuzzo, Rivoltini (b64-ol-06-06-1543) 2006; 55 Craig, Weissman, Horwich (b8-ol-06-06-1543) 1994; 78 Blachere, Li, Chandawarkar (b46-ol-06-06-1543) 1997; 186 Georgopoulos, Welch (b3-ol-06-06-1543) 1993; 9 Srivastava, DeLeo, Old (b12-ol-06-06-1543) 1986; 83 Klein, Sjogren, Klein, Hellstrom (b32-ol-06-06-1543) 1960; 20 Singh-Jasuja, Scherer, Hilf (b59-ol-06-06-1543) 2000; 30 Prehn, Main (b33-ol-06-06-1543) 1957; 18 Li, Qiao, Liu (b45-ol-06-06-1543) 2005; 11 Binder, Han, Srivastava (b50-ol-06-06-1543) 2000; 1 Udono, Srivastava (b37-ol-06-06-1543) 1994; 152 Wood, Srivastava, Bukowski (b17-ol-06-06-1543) 2008; 372 Lindquist, Craig (b2-ol-06-06-1543) 1988; 22 Enomoto, Bharti, Khaleque (b67-ol-06-06-1543) 2006; 177 Singh-Jasuja, Toes, Spee (b53-ol-06-06-1543) 2000; 191 Parsell, Lindquist (b5-ol-06-06-1543) 1993; 27 Suto, Srivastava (b52-ol-06-06-1543) 1995; 269 Matsutake, Srivastava (b54-ol-06-06-1543) 2000 Srivastava, Menoret, Basu, Binder, McQuade (b36-ol-06-06-1543) 1998; 8 Udono, Srivastava (b42-ol-06-06-1543) 1993; 178 Tamura, Peng, Liu, Daou, Srivastava (b14-ol-06-06-1543) 1997; 278 Berwin, Nicchitta (b26-ol-06-06-1543) 2001; 2 Janetzki, Palla, Rosenhauer, Lochs, Lewis, Srivastava (b43-ol-06-06-1543) 2000; 88 Gong, Zhang, Durfee (b68-ol-06-06-1543) 2010; 184 Zhu, Zhao, Burkholder (b40-ol-06-06-1543) 1996; 272 Nicchitta (b15-ol-06-06-1543) 1998; 10 Srivastava (b23-ol-06-06-1543) 2002; 2 Old, Clarke, Carswell (b34-ol-06-06-1543) 1962 Basu, Binder, Ramalingam, Srivastava (b51-ol-06-06-1543) 2001; 14 Moré, Breloer, von Bonin (b56-ol-06-06-1543) 2001; 13 Srivastava (b20-ol-06-06-1543) 2000; 1 Lehner, Bergmeier, Wang (b57-ol-06-06-1543) 2000; 30 Gao, Chen, Gao, Yang, Ma, Ren (b66-ol-06-06-1543) 2012; 28 Schild, Rammensee (b27-ol-06-06-1543) 2000; 1 Ullrich, Robinson, Law, Willingham, Appella (b35-ol-06-06-1543) 1986; 83 Gross (b31-ol-06-06-1543) 1943 Gething, Sambrook (b4-ol-06-06-1543) 1992; 355 Kovalchin, Murthy, Horattas, Guyton, Chandawarkar (b22-ol-06-06-1543) 2001; 1 Sato (key20180108110239_b19-ol-06-06-1543) 2001; 98 Baker-LePain (key20180108110239_b62-ol-06-06-1543) 2002; 196 Parsell (key20180108110239_b5-ol-06-06-1543) 1993; 27 Tamura (key20180108110239_b14-ol-06-06-1543) 1997; 278 Basu (key20180108110239_b51-ol-06-06-1543) 2001; 14 Wood (key20180108110239_b17-ol-06-06-1543) 2008; 372 Gross (key20180108110239_b31-ol-06-06-1543) 1943 Matsutake (key20180108110239_b54-ol-06-06-1543) 2000 Old (key20180108110239_b34-ol-06-06-1543) 1962 Li (key20180108110239_b9-ol-06-06-1543) 1993; 12 Abiru (key20180108110239_b48-ol-06-06-1543) 2001; 50 Janetzki (key20180108110239_b43-ol-06-06-1543) 2000; 88 Bukau (key20180108110239_b6-ol-06-06-1543) 2000; 101 Ritossa (key20180108110239_b1-ol-06-06-1543) 1962; 37 Srivastava (key20180108110239_b23-ol-06-06-1543) 2002; 2 Singh-Jasuja (key20180108110239_b53-ol-06-06-1543) 2000; 191 Klein (key20180108110239_b32-ol-06-06-1543) 1960; 20 Li (key20180108110239_b63-ol-06-06-1543) 2007; 148 Schild (key20180108110239_b27-ol-06-06-1543) 2000; 1 Moré (key20180108110239_b56-ol-06-06-1543) 2001; 13 Ullrich (key20180108110239_b35-ol-06-06-1543) 1986; 83 Nicchitta (key20180108110239_b15-ol-06-06-1543) 1998; 10 Bukau (key20180108110239_b41-ol-06-06-1543) 1998; 92 Georgopoulos (key20180108110239_b3-ol-06-06-1543) 1993; 9 Basu (key20180108110239_b55-ol-06-06-1543) 2000; 12 Murshid (key20180108110239_b65-ol-06-06-1543) 2013; 960 Berwin (key20180108110239_b26-ol-06-06-1543) 2001; 2 Gong (key20180108110239_b68-ol-06-06-1543) 2010; 184 Testori (key20180108110239_b16-ol-06-06-1543) 2008; 26 Singh-Jasuja (key20180108110239_b59-ol-06-06-1543) 2000; 30 Blachere (key20180108110239_b46-ol-06-06-1543) 1997; 186 Vanaja (key20180108110239_b13-ol-06-06-1543) 2000; 60 Udono (key20180108110239_b37-ol-06-06-1543) 1994; 152 Castelli (key20180108110239_b28-ol-06-06-1543) 2004; 53 Srivastava (key20180108110239_b29-ol-06-06-1543) 1984; 33 Binder (key20180108110239_b50-ol-06-06-1543) 2000; 1 Srivastava (key20180108110239_b20-ol-06-06-1543) 2000; 1 Craig (key20180108110239_b8-ol-06-06-1543) 1994; 78 Srivastava (key20180108110239_b49-ol-06-06-1543) 1994; 39 Suto (key20180108110239_b52-ol-06-06-1543) 1995; 269 Sherman (key20180108110239_b10-ol-06-06-1543) 2007; 1113 Srivastava (key20180108110239_b38-ol-06-06-1543) 1987; 84 Castelli (key20180108110239_b7-ol-06-06-1543) 2001; 61 Kovalchin (key20180108110239_b22-ol-06-06-1543) 2001; 1 Ciupitu (key20180108110239_b61-ol-06-06-1543) 2002; 51 Shinagawa (key20180108110239_b18-ol-06-06-1543) 2008; 57 Binder (key20180108110239_b60-ol-06-06-1543) 2000; 165 Gao (key20180108110239_b66-ol-06-06-1543) 2012; 28 Srivastava (key20180108110239_b12-ol-06-06-1543) 1986; 83 Li (key20180108110239_b45-ol-06-06-1543) 2005; 11 Srivastava (key20180108110239_b39-ol-06-06-1543) 1991; 167 Milani (key20180108110239_b11-ol-06-06-1543) 2002; 18 Udono (key20180108110239_b42-ol-06-06-1543) 1993; 178 Prehn (key20180108110239_b33-ol-06-06-1543) 1957; 18 Rivoltini (key20180108110239_b44-ol-06-06-1543) 2003; 171 Martin (key20180108110239_b47-ol-06-06-1543) 2000; 115 Pilla (key20180108110239_b64-ol-06-06-1543) 2006; 55 Enomoto (key20180108110239_b67-ol-06-06-1543) 2006; 177 Hoos (key20180108110239_b30-ol-06-06-1543) 2003; 2 Zhu (key20180108110239_b40-ol-06-06-1543) 1996; 272 Kojima (key20180108110239_b21-ol-06-06-1543) 2003; 14 Panjwani (key20180108110239_b58-ol-06-06-1543) 2002; 168 Schmitt (key20180108110239_b24-ol-06-06-1543) 2007; 81 Lindquist (key20180108110239_b2-ol-06-06-1543) 1988; 22 Srivastava (key20180108110239_b36-ol-06-06-1543) 1998; 8 Gething (key20180108110239_b4-ol-06-06-1543) 1992; 355 Srivastava (key20180108110239_b25-ol-06-06-1543) 2002; 20 Lehner (key20180108110239_b57-ol-06-06-1543) 2000; 30 17056519 - J Immunol. 2006 Nov 1;177(9):5946-55 9655479 - Immunity. 1998 Jun;8(6):657-65 2438686 - Proc Natl Acad Sci U S A. 1987 Jun;84(11):3807-11 11004674 - Int J Cancer. 2000 Oct 15;88(2):232-8 11290339 - Immunity. 2001 Mar;14(3):303-13 13756652 - Cancer Res. 1960 Dec;20:1561-72 23329490 - Methods Mol Biol. 2013;960:209-17 11861608 - Annu Rev Immunol. 2002;20:395-425 10786831 - Cell. 2000 Apr 14;101(2):119-22 14689240 - Cancer Immunol Immunother. 2004 Mar;53(3):227-33 3458189 - Proc Natl Acad Sci U S A. 1986 May;83(10):3407-11 14500642 - J Immunol. 2003 Oct 1;171(7):3467-74 12804136 - Hum Gene Ther. 2003 May 20;14(8):715-28 19949080 - J Immunol. 2010 Jan 1;184(1):488-96 11576445 - Traffic. 2001 Oct;2(10):690-7 10951244 - J Invest Dermatol. 2000 Aug;115(2):260-6 10940912 - Eur J Immunol. 2000 Aug;30(8):2211-5 16931602 - J Leukoc Biol. 2007 Jan;81(1):15-27 11375327 - Diabetes. 2001 Jun;50(6):1274-81 6698641 - Int J Cancer. 1984 Mar 15;33(3):417-22 12903802 - Expert Rev Vaccines. 2003 Jun;2(3):369-79 12537755 - Int J Hyperthermia. 2002 Nov-Dec;18(6):563-75 12747768 - Cancer Immun. 2001 Apr 27;1:7 8280473 - Annu Rev Cell Biol. 1993;9:601-34 11248808 - Nat Immunol. 2000 Aug;1(2):151-5 11913069 - Nat Rev Immunol. 2002 Mar;2(3):185-94 11535521 - Blood. 2001 Sep 15;98(6):1852-7 8344253 - EMBO J. 1993 Aug;12(8):3143-51 11941455 - Cancer Immunol Immunother. 2002 May;51(3):163-70 9311915 - Science. 1997 Oct 3;278(5335):117-20 9523119 - Curr Opin Immunol. 1998 Feb;10(1):103-9 10987274 - Cancer Res. 2000 Sep 1;60(17):4714-8 11196165 - Cancer Res. 2001 Jan 1;61(1):222-7 1711433 - Curr Top Microbiol Immunol. 1991;167:109-23 7914834 - Cell. 1994 Aug 12;78(3):365-72 11526092 - Int Immunol. 2001 Sep;13(9):1121-7 8276462 - Immunogenetics. 1994;39(2):93-8 17978282 - Ann N Y Acad Sci. 2007 Oct;1113:192-201 12461080 - J Exp Med. 2002 Dec 2;196(11):1447-59 13502695 - J Natl Cancer Inst. 1957 Jun;18(6):769-78 15958631 - Clin Cancer Res. 2005 Jun 15;11(12):4460-8 23007635 - Oncol Rep. 2012 Dec;28(6):1977-83 18281670 - J Clin Oncol. 2008 Feb 20;26(6):955-62 2853609 - Annu Rev Genet. 1988;22:631-77 8189059 - J Immunol. 1994 Jun 1;152(11):5398-403 16215718 - Cancer Immunol Immunother. 2006 Aug;55(8):958-68 11884472 - J Immunol. 2002 Mar 15;168(6):2997-3003 3458168 - Proc Natl Acad Sci U S A. 1986 May;83(10):3121-5 8376942 - J Exp Med. 1993 Oct 1;178(4):1391-6 10671216 - Eur J Immunol. 2000 Feb;30(2):594-603 11062489 - Nat Immunol. 2000 Nov;1(5):363-6 8658133 - Science. 1996 Jun 14;272(5268):1606-14 17628800 - Cancer Immunol Immunother. 2008 Feb;57(2):165-74 18602688 - Lancet. 2008 Jul 12;372(9633):145-54 9334371 - J Exp Med. 1997 Oct 20;186(8):1315-22 11248798 - Nat Immunol. 2000 Aug;1(2):100-1 17349014 - Clin Exp Immunol. 2007 Apr;148(1):136-45 10839811 - J Exp Med. 2000 Jun 5;191(11):1965-74 14492506 - Riv Ist Sieroter Ital. 1962 Mar-Apr;37:79-108 8122909 - Annu Rev Genet. 1993;27:437-96 7545313 - Science. 1995 Sep 15;269(5230):1585-8 11086034 - J Immunol. 2000 Dec 1;165(11):6029-35 9476895 - Cell. 1998 Feb 6;92(3):351-66 1731198 - Nature. 1992 Jan 2;355(6355):33-45 11058573 - Int Immunol. 2000 Nov;12(11):1539-46 |
| References_xml | – volume: 8 start-page: 657 year: 1998 end-page: 665 ident: b36-ol-06-06-1543 article-title: Heat shock proteins come of age: primitive functions acquire new roles in an adaptive world publication-title: Immunity – volume: 1 start-page: 7 year: 2001 ident: b22-ol-06-06-1543 article-title: Determinants of efficacy of immunotherapy with tumor-derived heat shock protein gp96 publication-title: Cancer Immun – volume: 22 start-page: 631 year: 1988 end-page: 677 ident: b2-ol-06-06-1543 article-title: The heat-shock proteins publication-title: Annu Rev Genet – volume: 355 start-page: 33 year: 1992 end-page: 45 ident: b4-ol-06-06-1543 article-title: Protein folding in the cell publication-title: Nature – volume: 78 start-page: 365 year: 1994 end-page: 372 ident: b8-ol-06-06-1543 article-title: Heat shock proteins and molecular chaperones: mediators of protein conformation and turnover in the cell publication-title: Cell – volume: 83 start-page: 3121 year: 1986 end-page: 3125 ident: b35-ol-06-06-1543 article-title: A mouse tumor-specific transplantation antigen is a heat shock-related protein publication-title: Proc Natl Acad Sci USA – volume: 272 start-page: 1606 year: 1996 end-page: 1614 ident: b40-ol-06-06-1543 article-title: Structural analysis of substrate binding by the molecular chaperone DnaK publication-title: Science – volume: 191 start-page: 1965 year: 2000 end-page: 1974 ident: b53-ol-06-06-1543 article-title: Cross-presentation of glycoprotein 96-associated antigens on major histocompatibility complex class I molecules requires receptor-mediated endocytosis publication-title: J Exp Med – volume: 186 start-page: 1315 year: 1997 end-page: 1322 ident: b46-ol-06-06-1543 article-title: Heat shock protein-peptide complexes, reconstituted in vitro, elicit peptide-specific cytotoxic T lymphocyte response and tumor immunity publication-title: J Exp Med – volume: 196 start-page: 1447 year: 2002 end-page: 1459 ident: b62-ol-06-06-1543 article-title: GRP94 (gp96) and GRP94 N-terminal geldanamycin binding domain elicit tissue nonrestricted tumor suppression publication-title: J Exp Med – volume: 10 start-page: 103 year: 1998 end-page: 109 ident: b15-ol-06-06-1543 article-title: Biochemical, cell biological and immunological issues surrounding the endoplasmic reticulum chaperone GRP94/gp96 publication-title: Curr Opin Immunol – start-page: 378 year: 2000 ident: b54-ol-06-06-1543 article-title: CD91 is involved in MHC class II presentation of gp96-chaperoned peptides publication-title: Cell Stress Chaperones – volume: 148 start-page: 136 year: 2007 end-page: 145 ident: b63-ol-06-06-1543 article-title: Human ovarian tumour-derived chaperone-rich cell lysate (CRCL) elicits T cell responses in vitro publication-title: Clin Exp Immunol – volume: 18 start-page: 769 year: 1957 end-page: 778 ident: b33-ol-06-06-1543 article-title: Immunity to methylcholanthrene-induced sarcomas publication-title: J Natl Cancer Inst – volume: 269 start-page: 1585 year: 1995 end-page: 1588 ident: b52-ol-06-06-1543 article-title: A mechanism for the specific immunogenicity of heat shock protein-chaperoned peptides publication-title: Science – volume: 12 start-page: 3143 year: 1993 end-page: 3151 ident: b9-ol-06-06-1543 article-title: Tumor rejection antigen gp96/grp94 is an ATPase: implications for protein folding and antigen presentation publication-title: EMBO J – volume: 55 start-page: 958 year: 2006 end-page: 968 ident: b64-ol-06-06-1543 article-title: A phase II trial of vaccination with autologous, tumor-derived heat-shock protein peptide complexes Gp96, in combination with GM-CSF and interferon-alpha in metastatic melanoma patients publication-title: Cancer Immunol Immunother – volume: 2 start-page: 185 year: 2002 end-page: 194 ident: b23-ol-06-06-1543 article-title: Roles of heat-shock proteins in innate and adaptive immunity publication-title: Nat Rev Immunol – volume: 101 start-page: 119 year: 2000 end-page: 122 ident: b6-ol-06-06-1543 article-title: Getting newly synthesized proteins into shape publication-title: Cell – volume: 168 start-page: 2997 year: 2002 end-page: 3003 ident: b58-ol-06-06-1543 article-title: Heat shock proteins gp96 and hsp70 activate the release of nitric oxide by APCs publication-title: J Immunol – volume: 53 start-page: 227 year: 2004 end-page: 233 ident: b28-ol-06-06-1543 article-title: Heat shock proteins: biological functions and clinical application as personalized vaccines for human cancer publication-title: Cancer Immunol Immunother – volume: 39 start-page: 93 year: 1994 end-page: 98 ident: b49-ol-06-06-1543 article-title: Heat shock proteins transfer peptides during antigen processing and CTL priming publication-title: Immunogenetics – volume: 12 start-page: 1539 year: 2000 end-page: 1546 ident: b55-ol-06-06-1543 article-title: Necrotic but not apoptotic cell death releases heat shock proteins, which deliver a partial maturation signal to dendritic cells and activate the NF-kappa B pathway publication-title: Int Immunol – volume: 30 start-page: 2211 year: 2000 end-page: 2215 ident: b59-ol-06-06-1543 article-title: The heat shock protein gp96 induces maturation of dendritic cells and down-regulation of its receptor publication-title: Eur J Immunol – volume: 1113 start-page: 192 year: 2007 end-page: 201 ident: b10-ol-06-06-1543 article-title: Heat shock proteins in cancer publication-title: Ann N Y Acad Sci – volume: 33 start-page: 417 year: 1984 end-page: 422 ident: b29-ol-06-06-1543 article-title: The serologically unique cell surface antigen of Zajdela ascitic hepatoma is also its tumor-associated transplantation antigen publication-title: Int J Cancer – volume: 165 start-page: 6029 year: 2000 end-page: 6035 ident: b60-ol-06-06-1543 article-title: Cutting edge: heat shock protein gp96 induces maturation and migration of CD11c+ cells in vivo publication-title: J Immunol – volume: 57 start-page: 165 year: 2008 end-page: 174 ident: b18-ol-06-06-1543 article-title: Immunotherapy with dendritic cells pulsed with tumor-derived gp96 against murine lung cancer is effective through immune response of CD8+ cytotoxic T lymphocytes and natural killer cells publication-title: Cancer Immunol Immunother – volume: 98 start-page: 1852 year: 2001 end-page: 1857 ident: b19-ol-06-06-1543 article-title: Immunotherapy using heat-shock protein preparations of leukemia cells after syngeneic bone marrow transplantation in mice publication-title: Blood – volume: 92 start-page: 351 year: 1998 end-page: 366 ident: b41-ol-06-06-1543 article-title: The Hsp70 and Hsp60 chaperone machines publication-title: Cell – start-page: 80 year: 1962 end-page: 106 ident: b34-ol-06-06-1543 article-title: Antigenic properties of chemically induced tumors publication-title: Ann NY Acad Sci – volume: 14 start-page: 303 year: 2001 end-page: 313 ident: b51-ol-06-06-1543 article-title: CD91 is a common receptor for heat shock proteins gp96, hsp90, hsp70 and calreticulin publication-title: Immunity – volume: 61 start-page: 222 year: 2001 end-page: 227 ident: b7-ol-06-06-1543 article-title: Human heat shock protein 70 peptide complexes specifically activate antimelanoma T cells publication-title: Cancer Res – volume: 18 start-page: 563 year: 2002 end-page: 575 ident: b11-ol-06-06-1543 article-title: Heat shock protein 70: role in antigen presentation and immune stimulation publication-title: Int J Hyperthermia – start-page: 323 year: 1943 end-page: 326 ident: b31-ol-06-06-1543 article-title: Intradermal immunization of C3H mice against a sarcoma that originated in an animal of the same line publication-title: Cancer Res – volume: 51 start-page: 163 year: 2002 end-page: 170 ident: b61-ol-06-06-1543 article-title: Immunization with heat shock protein 70 from methylcholanthrene-induced sarcomas induces tumor protection correlating with in vitro T cell responses publication-title: Cancer Immunol Immunother – volume: 115 start-page: 260 year: 2000 end-page: 266 ident: b47-ol-06-06-1543 article-title: Peptide immunization indicates that CD8+ T cells are the dominant effector cells in trinitrophenyl-specific contact hypersensitivity publication-title: J Invest Dermatol – volume: 372 start-page: 145 year: 2008 end-page: 154 ident: b17-ol-06-06-1543 article-title: An adjuvant autologous therapeutic vaccine (HSPPC-96; vitespen) versus observation alone for patients at high risk of recurrence after nephrectomy for renal cell carcinoma: a multicentre, open-label, randomised phase III trial publication-title: Lancet – volume: 177 start-page: 5946 year: 2006 end-page: 5955 ident: b67-ol-06-06-1543 article-title: Enhanced immunogenicity of heat shock protein 70 peptide complexes from dendritic cell-tumor fusion cells publication-title: J Immunol – volume: 20 start-page: 395 year: 2002 end-page: 425 ident: b25-ol-06-06-1543 article-title: Interaction of heat shock proteins with peptides and antigen presenting cells: chaperoning of the innate and adaptive immune responses publication-title: Annu Rev Immunol – volume: 27 start-page: 437 year: 1993 end-page: 496 ident: b5-ol-06-06-1543 article-title: The function of heat-shock proteins in stress tolerance: degradation and reactivation of damaged proteins publication-title: Annu Rev Genet – volume: 1 start-page: 100 year: 2000 end-page: 101 ident: b27-ol-06-06-1543 article-title: gp96 - the immune system's Swiss army knife publication-title: Nat Immunol – volume: 11 start-page: 4460 year: 2005 end-page: 4468 ident: b45-ol-06-06-1543 article-title: Combination of imatinib mesylate with autologous leukocyte-derived heat shock protein and chronic myelogenous leukemia publication-title: Clin Cancer Res – volume: 84 start-page: 3807 year: 1987 end-page: 3811 ident: b38-ol-06-06-1543 article-title: 5′-structural analysis of genes encoding polymorphic antigens of chemically induced tumors publication-title: Proc Natl Acad Sci USA – volume: 88 start-page: 232 year: 2000 end-page: 238 ident: b43-ol-06-06-1543 article-title: Immunization of cancer patients with autologous cancer-derived heat shock protein gp96 preparations: a pilot study publication-title: Int J Cancer – volume: 26 start-page: 955 year: 2008 end-page: 962 ident: b16-ol-06-06-1543 article-title: Phase III comparison of vitespen, an autologous tumor-derived heat shock protein gp96 peptide complex vaccine, with physician's choice of treatment for stage IV melanoma: the C-100-21 Study Group publication-title: J Clin Oncol – volume: 50 start-page: 1274 year: 2001 end-page: 1281 ident: b48-ol-06-06-1543 article-title: Peptide and major histocompatibility complex-specific breaking of humoral tolerance to native insulin with the B9-23 peptide in diabetes-prone and normal mice publication-title: Diabetes – volume: 2 start-page: 690 year: 2001 end-page: 697 ident: b26-ol-06-06-1543 article-title: To find the road traveled to tumor immunity: the trafficking itineraries of molecular chaperones in antigen-presenting cells publication-title: Traffic – volume: 184 start-page: 488 year: 2010 end-page: 496 ident: b68-ol-06-06-1543 article-title: A heat shock protein 70-based vaccine with enhanced immunogenicity for clinical use publication-title: J Immunol – volume: 152 start-page: 5398 year: 1994 end-page: 5403 ident: b37-ol-06-06-1543 article-title: Comparison of tumor-specific immunogenicities of stress-induced proteins gp96, hsp90 and hsp70 publication-title: J Immunol – volume: 167 start-page: 109 year: 1991 end-page: 123 ident: b39-ol-06-06-1543 article-title: Stress-induced proteins in immune response to cancer publication-title: Curr Top Microbiol Immunol – volume: 171 start-page: 3467 year: 2003 end-page: 3474 ident: b44-ol-06-06-1543 article-title: Human tumor-derived heat shock protein 96 mediates in vitro activation and in vivo expansion of melanoma- and colon carcinoma-specific T cells publication-title: J Immunol – volume: 14 start-page: 715 year: 2003 end-page: 728 ident: b21-ol-06-06-1543 article-title: Granulocyte-macrophage colony-stimulating factor gene-transduced tumor cells combined with tumor-derived gp96 inhibit tumor growth in mice publication-title: Hum Gene Ther – volume: 2 start-page: 369 year: 2003 end-page: 379 ident: b30-ol-06-06-1543 article-title: Vaccination with heat shock protein-peptide complexes: from basic science to clinical applications publication-title: Expert Rev Vaccines – volume: 60 start-page: 4714 year: 2000 end-page: 4718 ident: b13-ol-06-06-1543 article-title: Tumor prevention and antitumor immunity with heat shock protein 70 induced by 15-deoxy-delta12,14-prostaglandin J2 in transgenic adenocarcinoma of mouse prostate cells publication-title: Cancer Res – volume: 20 start-page: 1561 year: 1960 end-page: 1572 ident: b32-ol-06-06-1543 article-title: Demonstration of resistance against methylcholanthrene-induced sarcomas in the primary autochthonous host publication-title: Cancer Res – volume: 28 start-page: 1977 year: 2012 end-page: 1983 ident: b66-ol-06-06-1543 article-title: A new purification method for enhancing the immunogenicity of heat shock protein 70-peptide complexes publication-title: Oncol Rep – volume: 37 start-page: 79 year: 1962 end-page: 108 ident: b1-ol-06-06-1543 article-title: Problems of prophylactic vaccinations of infants publication-title: Riv Ist Sieroter Ital – volume: 9 start-page: 601 year: 1993 end-page: 634 ident: b3-ol-06-06-1543 article-title: Role of the major heat shock proteins as molecular chaperones publication-title: Annu Rev Cell Biol – volume: 278 start-page: 117 year: 1997 end-page: 120 ident: b14-ol-06-06-1543 article-title: Immunotherapy of tumors with autologous tumor-derived heat shock protein preparations publication-title: Science – volume: 13 start-page: 1121 year: 2001 end-page: 1127 ident: b56-ol-06-06-1543 article-title: Eukaryotic heat shock proteins as molecular links in innate and adaptive immune responses: Hsp60-mediated activation of cytotoxic T cells publication-title: Int Immunol – volume: 960 start-page: 209 year: 2013 end-page: 217 ident: b65-ol-06-06-1543 article-title: Purification, preparation and use of chaperone-peptide complexes for tumor immunotherapy publication-title: Methods Mol Biol – volume: 83 start-page: 3407 year: 1986 end-page: 3411 ident: b12-ol-06-06-1543 article-title: Tumor rejection antigens of chemically induced sarcomas of inbred mice publication-title: Proc Natl Acad Sci USA – volume: 1 start-page: 363 year: 2000 end-page: 366 ident: b20-ol-06-06-1543 article-title: Immunotherapy of human cancer: lessons from mice publication-title: Nat Immunol – volume: 1 start-page: 151 year: 2000 end-page: 155 ident: b50-ol-06-06-1543 article-title: CD91: a receptor for heat shock protein gp96 publication-title: Nat Immunol – volume: 178 start-page: 1391 year: 1993 end-page: 1396 ident: b42-ol-06-06-1543 article-title: Heat shock protein 70-associated peptides elicit specific cancer immunity publication-title: J Exp Med – volume: 81 start-page: 15 year: 2007 end-page: 27 ident: b24-ol-06-06-1543 article-title: Intracellular and extracellular functions of heat shock proteins: repercussions in cancer therapy publication-title: J Leukoc Biol – volume: 30 start-page: 594 year: 2000 end-page: 603 ident: b57-ol-06-06-1543 article-title: Heat shock proteins generate beta-chemokines which function as innate adjuvants enhancing adaptive immunity publication-title: Eur J Immunol – volume: 57 start-page: 165 year: 2008 ident: key20180108110239_b18-ol-06-06-1543 article-title: Immunotherapy with dendritic cells pulsed with tumor-derived gp96 against murine lung cancer is effective through immune response of CD8+ cytotoxic T lymphocytes and natural killer cells publication-title: Cancer Immunol Immunother doi: 10.1007/s00262-007-0359-3 – volume: 51 start-page: 163 year: 2002 ident: key20180108110239_b61-ol-06-06-1543 article-title: Immunization with heat shock protein 70 from methylcholanthrene-induced sarcomas induces tumor protection correlating with in vitro T cell responses publication-title: Cancer Immunol Immunother doi: 10.1007/s00262-002-0263-9 – volume: 39 start-page: 93 year: 1994 ident: key20180108110239_b49-ol-06-06-1543 article-title: Heat shock proteins transfer peptides during antigen processing and CTL priming publication-title: Immunogenetics doi: 10.1007/BF00188611 – volume: 22 start-page: 631 year: 1988 ident: key20180108110239_b2-ol-06-06-1543 article-title: The heat-shock proteins publication-title: Annu Rev Genet doi: 10.1146/annurev.ge.22.120188.003215 – volume: 9 start-page: 601 year: 1993 ident: key20180108110239_b3-ol-06-06-1543 article-title: Role of the major heat shock proteins as molecular chaperones publication-title: Annu Rev Cell Biol doi: 10.1146/annurev.cb.09.110193.003125 – volume: 30 start-page: 594 year: 2000 ident: key20180108110239_b57-ol-06-06-1543 article-title: Heat shock proteins generate beta-chemokines which function as innate adjuvants enhancing adaptive immunity publication-title: Eur J Immunol doi: 10.1002/1521-4141(200002)30:2<594::AID-IMMU594>3.0.CO;2-1 – volume: 960 start-page: 209 year: 2013 ident: key20180108110239_b65-ol-06-06-1543 article-title: Purification, preparation and use of chaperone-peptide complexes for tumor immunotherapy publication-title: Methods Mol Biol doi: 10.1007/978-1-62703-218-6_17 – start-page: 378 year: 2000 ident: key20180108110239_b54-ol-06-06-1543 article-title: CD91 is involved in MHC class II presentation of gp96-chaperoned peptides publication-title: Cell Stress Chaperones – volume: 184 start-page: 488 year: 2010 ident: key20180108110239_b68-ol-06-06-1543 article-title: A heat shock protein 70-based vaccine with enhanced immunogenicity for clinical use publication-title: J Immunol doi: 10.4049/jimmunol.0902255 – volume: 60 start-page: 4714 year: 2000 ident: key20180108110239_b13-ol-06-06-1543 article-title: Tumor prevention and antitumor immunity with heat shock protein 70 induced by 15-deoxy-delta12,14-prostaglandin J2 in transgenic adenocarcinoma of mouse prostate cells publication-title: Cancer Res – volume: 92 start-page: 351 year: 1998 ident: key20180108110239_b41-ol-06-06-1543 article-title: The Hsp70 and Hsp60 chaperone machines publication-title: Cell doi: 10.1016/S0092-8674(00)80928-9 – volume: 171 start-page: 3467 year: 2003 ident: key20180108110239_b44-ol-06-06-1543 article-title: Human tumor-derived heat shock protein 96 mediates in vitro activation and in vivo expansion of melanoma- and colon carcinoma-specific T cells publication-title: J Immunol doi: 10.4049/jimmunol.171.7.3467 – volume: 1 start-page: 151 year: 2000 ident: key20180108110239_b50-ol-06-06-1543 article-title: CD91: a receptor for heat shock protein gp96 publication-title: Nat Immunol doi: 10.1038/77835 – volume: 1 start-page: 100 year: 2000 ident: key20180108110239_b27-ol-06-06-1543 article-title: gp96 - the immune system’s Swiss army knife publication-title: Nat Immunol doi: 10.1038/77770 – volume: 167 start-page: 109 year: 1991 ident: key20180108110239_b39-ol-06-06-1543 article-title: Stress-induced proteins in immune response to cancer publication-title: Curr Top Microbiol Immunol – volume: 2 start-page: 185 year: 2002 ident: key20180108110239_b23-ol-06-06-1543 article-title: Roles of heat-shock proteins in innate and adaptive immunity publication-title: Nat Rev Immunol doi: 10.1038/nri749 – volume: 355 start-page: 33 year: 1992 ident: key20180108110239_b4-ol-06-06-1543 article-title: Protein folding in the cell publication-title: Nature doi: 10.1038/355033a0 – volume: 26 start-page: 955 year: 2008 ident: key20180108110239_b16-ol-06-06-1543 article-title: Phase III comparison of vitespen, an autologous tumor-derived heat shock protein gp96 peptide complex vaccine, with physician’s choice of treatment for stage IV melanoma: the C-100-21 Study Group publication-title: J Clin Oncol doi: 10.1200/JCO.2007.11.9941 – volume: 272 start-page: 1606 year: 1996 ident: key20180108110239_b40-ol-06-06-1543 article-title: Structural analysis of substrate binding by the molecular chaperone DnaK publication-title: Science doi: 10.1126/science.272.5268.1606 – volume: 30 start-page: 2211 year: 2000 ident: key20180108110239_b59-ol-06-06-1543 article-title: The heat shock protein gp96 induces maturation of dendritic cells and down-regulation of its receptor publication-title: Eur J Immunol doi: 10.1002/1521-4141(2000)30:8<2211::AID-IMMU2211>3.0.CO;2-0 – volume: 10 start-page: 103 year: 1998 ident: key20180108110239_b15-ol-06-06-1543 article-title: Biochemical, cell biological and immunological issues surrounding the endoplasmic reticulum chaperone GRP94/gp96 publication-title: Curr Opin Immunol doi: 10.1016/S0952-7915(98)80039-3 – start-page: 323 year: 1943 ident: key20180108110239_b31-ol-06-06-1543 article-title: Intradermal immunization of C3H mice against a sarcoma that originated in an animal of the same line publication-title: Cancer Res – volume: 37 start-page: 79 year: 1962 ident: key20180108110239_b1-ol-06-06-1543 article-title: Problems of prophylactic vaccinations of infants publication-title: Riv Ist Sieroter Ital – volume: 178 start-page: 1391 year: 1993 ident: key20180108110239_b42-ol-06-06-1543 article-title: Heat shock protein 70-associated peptides elicit specific cancer immunity publication-title: J Exp Med doi: 10.1084/jem.178.4.1391 – volume: 115 start-page: 260 year: 2000 ident: key20180108110239_b47-ol-06-06-1543 article-title: Peptide immunization indicates that CD8+ T cells are the dominant effector cells in trinitrophenyl-specific contact hypersensitivity publication-title: J Invest Dermatol doi: 10.1046/j.1523-1747.2000.00038.x – volume: 50 start-page: 1274 year: 2001 ident: key20180108110239_b48-ol-06-06-1543 article-title: Peptide and major histocompatibility complex-specific breaking of humoral tolerance to native insulin with the B9-23 peptide in diabetes-prone and normal mice publication-title: Diabetes doi: 10.2337/diabetes.50.6.1274 – volume: 14 start-page: 303 year: 2001 ident: key20180108110239_b51-ol-06-06-1543 article-title: CD91 is a common receptor for heat shock proteins gp96, hsp90, hsp70 and calreticulin publication-title: Immunity doi: 10.1016/S1074-7613(01)00111-X – volume: 148 start-page: 136 year: 2007 ident: key20180108110239_b63-ol-06-06-1543 article-title: Human ovarian tumour-derived chaperone-rich cell lysate (CRCL) elicits T cell responses in vitro publication-title: Clin Exp Immunol doi: 10.1111/j.1365-2249.2007.03323.x – volume: 2 start-page: 690 year: 2001 ident: key20180108110239_b26-ol-06-06-1543 article-title: To find the road traveled to tumor immunity: the trafficking itineraries of molecular chaperones in antigen-presenting cells publication-title: Traffic doi: 10.1034/j.1600-0854.2001.21003.x – volume: 372 start-page: 145 year: 2008 ident: key20180108110239_b17-ol-06-06-1543 article-title: An adjuvant autologous therapeutic vaccine (HSPPC-96; vitespen) versus observation alone for patients at high risk of recurrence after nephrectomy for renal cell carcinoma: a multicentre, open-label, randomised phase III trial publication-title: Lancet doi: 10.1016/S0140-6736(08)60697-2 – volume: 83 start-page: 3121 year: 1986 ident: key20180108110239_b35-ol-06-06-1543 article-title: A mouse tumor-specific transplantation antigen is a heat shock-related protein publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.83.10.3121 – volume: 152 start-page: 5398 year: 1994 ident: key20180108110239_b37-ol-06-06-1543 article-title: Comparison of tumor-specific immunogenicities of stress-induced proteins gp96, hsp90 and hsp70 publication-title: J Immunol doi: 10.4049/jimmunol.152.11.5398 – volume: 1 start-page: 7 year: 2001 ident: key20180108110239_b22-ol-06-06-1543 article-title: Determinants of efficacy of immunotherapy with tumor-derived heat shock protein gp96 publication-title: Cancer Immun – volume: 84 start-page: 3807 year: 1987 ident: key20180108110239_b38-ol-06-06-1543 article-title: 5′-structural analysis of genes encoding polymorphic antigens of chemically induced tumors publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.84.11.3807 – volume: 2 start-page: 369 year: 2003 ident: key20180108110239_b30-ol-06-06-1543 article-title: Vaccination with heat shock protein-peptide complexes: from basic science to clinical applications publication-title: Expert Rev Vaccines doi: 10.1586/14760584.2.3.369 – volume: 27 start-page: 437 year: 1993 ident: key20180108110239_b5-ol-06-06-1543 article-title: The function of heat-shock proteins in stress tolerance: degradation and reactivation of damaged proteins publication-title: Annu Rev Genet doi: 10.1146/annurev.ge.27.120193.002253 – volume: 101 start-page: 119 year: 2000 ident: key20180108110239_b6-ol-06-06-1543 article-title: Getting newly synthesized proteins into shape publication-title: Cell doi: 10.1016/S0092-8674(00)80806-5 – volume: 11 start-page: 4460 year: 2005 ident: key20180108110239_b45-ol-06-06-1543 article-title: Combination of imatinib mesylate with autologous leukocyte-derived heat shock protein and chronic myelogenous leukemia publication-title: Clin Cancer Res doi: 10.1158/1078-0432.CCR-05-0250 – volume: 18 start-page: 769 year: 1957 ident: key20180108110239_b33-ol-06-06-1543 article-title: Immunity to methylcholanthrene-induced sarcomas publication-title: J Natl Cancer Inst – volume: 186 start-page: 1315 year: 1997 ident: key20180108110239_b46-ol-06-06-1543 article-title: Heat shock protein-peptide complexes, reconstituted in vitro, elicit peptide-specific cytotoxic T lymphocyte response and tumor immunity publication-title: J Exp Med doi: 10.1084/jem.186.8.1315 – volume: 28 start-page: 1977 year: 2012 ident: key20180108110239_b66-ol-06-06-1543 article-title: A new purification method for enhancing the immunogenicity of heat shock protein 70-peptide complexes publication-title: Oncol Rep doi: 10.3892/or.2012.2051 – volume: 196 start-page: 1447 year: 2002 ident: key20180108110239_b62-ol-06-06-1543 article-title: GRP94 (gp96) and GRP94 N-terminal geldanamycin binding domain elicit tissue nonrestricted tumor suppression publication-title: J Exp Med doi: 10.1084/jem.20020436 – volume: 78 start-page: 365 year: 1994 ident: key20180108110239_b8-ol-06-06-1543 article-title: Heat shock proteins and molecular chaperones: mediators of protein conformation and turnover in the cell publication-title: Cell doi: 10.1016/0092-8674(94)90416-2 – volume: 61 start-page: 222 year: 2001 ident: key20180108110239_b7-ol-06-06-1543 article-title: Human heat shock protein 70 peptide complexes specifically activate antimelanoma T cells publication-title: Cancer Res – volume: 1113 start-page: 192 year: 2007 ident: key20180108110239_b10-ol-06-06-1543 article-title: Heat shock proteins in cancer publication-title: Ann N Y Acad Sci doi: 10.1196/annals.1391.030 – volume: 83 start-page: 3407 year: 1986 ident: key20180108110239_b12-ol-06-06-1543 article-title: Tumor rejection antigens of chemically induced sarcomas of inbred mice publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.83.10.3407 – volume: 20 start-page: 395 year: 2002 ident: key20180108110239_b25-ol-06-06-1543 article-title: Interaction of heat shock proteins with peptides and antigen presenting cells: chaperoning of the innate and adaptive immune responses publication-title: Annu Rev Immunol doi: 10.1146/annurev.immunol.20.100301.064801 – volume: 33 start-page: 417 year: 1984 ident: key20180108110239_b29-ol-06-06-1543 article-title: The serologically unique cell surface antigen of Zajdela ascitic hepatoma is also its tumor-associated transplantation antigen publication-title: Int J Cancer doi: 10.1002/ijc.2910330321 – volume: 8 start-page: 657 year: 1998 ident: key20180108110239_b36-ol-06-06-1543 article-title: Heat shock proteins come of age: primitive functions acquire new roles in an adaptive world publication-title: Immunity doi: 10.1016/S1074-7613(00)80570-1 – volume: 55 start-page: 958 year: 2006 ident: key20180108110239_b64-ol-06-06-1543 article-title: A phase II trial of vaccination with autologous, tumor-derived heat-shock protein peptide complexes Gp96, in combination with GM-CSF and interferon-alpha in metastatic melanoma patients publication-title: Cancer Immunol Immunother doi: 10.1007/s00262-005-0084-8 – volume: 1 start-page: 363 year: 2000 ident: key20180108110239_b20-ol-06-06-1543 article-title: Immunotherapy of human cancer: lessons from mice publication-title: Nat Immunol doi: 10.1038/80795 – volume: 20 start-page: 1561 year: 1960 ident: key20180108110239_b32-ol-06-06-1543 article-title: Demonstration of resistance against methylcholanthrene-induced sarcomas in the primary autochthonous host publication-title: Cancer Res – volume: 18 start-page: 563 year: 2002 ident: key20180108110239_b11-ol-06-06-1543 article-title: Heat shock protein 70: role in antigen presentation and immune stimulation publication-title: Int J Hyperthermia doi: 10.1080/02656730210166140 – volume: 98 start-page: 1852 year: 2001 ident: key20180108110239_b19-ol-06-06-1543 article-title: Immunotherapy using heat-shock protein preparations of leukemia cells after syngeneic bone marrow transplantation in mice publication-title: Blood doi: 10.1182/blood.V98.6.1852 – volume: 12 start-page: 1539 year: 2000 ident: key20180108110239_b55-ol-06-06-1543 article-title: Necrotic but not apoptotic cell death releases heat shock proteins, which deliver a partial maturation signal to dendritic cells and activate the NF-kappa B pathway publication-title: Int Immunol doi: 10.1093/intimm/12.11.1539 – volume: 88 start-page: 232 year: 2000 ident: key20180108110239_b43-ol-06-06-1543 article-title: Immunization of cancer patients with autologous cancer-derived heat shock protein gp96 preparations: a pilot study publication-title: Int J Cancer doi: 10.1002/1097-0215(20001015)88:2<232::AID-IJC14>3.0.CO;2-8 – volume: 14 start-page: 715 year: 2003 ident: key20180108110239_b21-ol-06-06-1543 article-title: Granulocyte-macrophage colony-stimulating factor gene-transduced tumor cells combined with tumor-derived gp96 inhibit tumor growth in mice publication-title: Hum Gene Ther doi: 10.1089/104303403765255129 – volume: 191 start-page: 1965 year: 2000 ident: key20180108110239_b53-ol-06-06-1543 article-title: Cross-presentation of glycoprotein 96-associated antigens on major histocompatibility complex class I molecules requires receptor-mediated endocytosis publication-title: J Exp Med doi: 10.1084/jem.191.11.1965 – volume: 269 start-page: 1585 year: 1995 ident: key20180108110239_b52-ol-06-06-1543 article-title: A mechanism for the specific immunogenicity of heat shock protein-chaperoned peptides publication-title: Science doi: 10.1126/science.7545313 – volume: 165 start-page: 6029 year: 2000 ident: key20180108110239_b60-ol-06-06-1543 article-title: Cutting edge: heat shock protein gp96 induces maturation and migration of CD11c+ cells in vivo publication-title: J Immunol doi: 10.4049/jimmunol.165.11.6029 – volume: 12 start-page: 3143 year: 1993 ident: key20180108110239_b9-ol-06-06-1543 article-title: Tumor rejection antigen gp96/grp94 is an ATPase: implications for protein folding and antigen presentation publication-title: EMBO J doi: 10.1002/j.1460-2075.1993.tb05983.x – start-page: 80 year: 1962 ident: key20180108110239_b34-ol-06-06-1543 article-title: Antigenic properties of chemically induced tumors publication-title: Ann NY Acad Sci doi: 10.1111/j.1749-6632.1962.tb26446.x – volume: 81 start-page: 15 year: 2007 ident: key20180108110239_b24-ol-06-06-1543 article-title: Intracellular and extracellular functions of heat shock proteins: repercussions in cancer therapy publication-title: J Leukoc Biol doi: 10.1189/jlb.0306167 – volume: 278 start-page: 117 year: 1997 ident: key20180108110239_b14-ol-06-06-1543 article-title: Immunotherapy of tumors with autologous tumor-derived heat shock protein preparations publication-title: Science doi: 10.1126/science.278.5335.117 – volume: 168 start-page: 2997 year: 2002 ident: key20180108110239_b58-ol-06-06-1543 article-title: Heat shock proteins gp96 and hsp70 activate the release of nitric oxide by APCs publication-title: J Immunol doi: 10.4049/jimmunol.168.6.2997 – volume: 177 start-page: 5946 year: 2006 ident: key20180108110239_b67-ol-06-06-1543 article-title: Enhanced immunogenicity of heat shock protein 70 peptide complexes from dendritic cell-tumor fusion cells publication-title: J Immunol doi: 10.4049/jimmunol.177.9.5946 – volume: 53 start-page: 227 year: 2004 ident: key20180108110239_b28-ol-06-06-1543 article-title: Heat shock proteins: biological functions and clinical application as personalized vaccines for human cancer publication-title: Cancer Immunol Immunother doi: 10.1007/s00262-003-0481-9 – volume: 13 start-page: 1121 year: 2001 ident: key20180108110239_b56-ol-06-06-1543 article-title: Eukaryotic heat shock proteins as molecular links in innate and adaptive immune responses: Hsp60-mediated activation of cytotoxic T cells publication-title: Int Immunol doi: 10.1093/intimm/13.9.1121 – reference: 7914834 - Cell. 1994 Aug 12;78(3):365-72 – reference: 2438686 - Proc Natl Acad Sci U S A. 1987 Jun;84(11):3807-11 – reference: 9311915 - Science. 1997 Oct 3;278(5335):117-20 – reference: 14500642 - J Immunol. 2003 Oct 1;171(7):3467-74 – reference: 8276462 - Immunogenetics. 1994;39(2):93-8 – reference: 1731198 - Nature. 1992 Jan 2;355(6355):33-45 – reference: 11196165 - Cancer Res. 2001 Jan 1;61(1):222-7 – reference: 14689240 - Cancer Immunol Immunother. 2004 Mar;53(3):227-33 – reference: 23007635 - Oncol Rep. 2012 Dec;28(6):1977-83 – reference: 16215718 - Cancer Immunol Immunother. 2006 Aug;55(8):958-68 – reference: 11535521 - Blood. 2001 Sep 15;98(6):1852-7 – reference: 2853609 - Annu Rev Genet. 1988;22:631-77 – reference: 17056519 - J Immunol. 2006 Nov 1;177(9):5946-55 – reference: 18281670 - J Clin Oncol. 2008 Feb 20;26(6):955-62 – reference: 11004674 - Int J Cancer. 2000 Oct 15;88(2):232-8 – reference: 23329490 - Methods Mol Biol. 2013;960:209-17 – reference: 6698641 - Int J Cancer. 1984 Mar 15;33(3):417-22 – reference: 1711433 - Curr Top Microbiol Immunol. 1991;167:109-23 – reference: 11375327 - Diabetes. 2001 Jun;50(6):1274-81 – reference: 3458168 - Proc Natl Acad Sci U S A. 1986 May;83(10):3121-5 – reference: 11086034 - J Immunol. 2000 Dec 1;165(11):6029-35 – reference: 18602688 - Lancet. 2008 Jul 12;372(9633):145-54 – reference: 8280473 - Annu Rev Cell Biol. 1993;9:601-34 – reference: 10940912 - Eur J Immunol. 2000 Aug;30(8):2211-5 – reference: 17349014 - Clin Exp Immunol. 2007 Apr;148(1):136-45 – reference: 11058573 - Int Immunol. 2000 Nov;12(11):1539-46 – reference: 14492506 - Riv Ist Sieroter Ital. 1962 Mar-Apr;37:79-108 – reference: 12804136 - Hum Gene Ther. 2003 May 20;14(8):715-28 – reference: 11290339 - Immunity. 2001 Mar;14(3):303-13 – reference: 11941455 - Cancer Immunol Immunother. 2002 May;51(3):163-70 – reference: 11526092 - Int Immunol. 2001 Sep;13(9):1121-7 – reference: 13756652 - Cancer Res. 1960 Dec;20:1561-72 – reference: 11248798 - Nat Immunol. 2000 Aug;1(2):100-1 – reference: 8189059 - J Immunol. 1994 Jun 1;152(11):5398-403 – reference: 10987274 - Cancer Res. 2000 Sep 1;60(17):4714-8 – reference: 13502695 - J Natl Cancer Inst. 1957 Jun;18(6):769-78 – reference: 7545313 - Science. 1995 Sep 15;269(5230):1585-8 – reference: 10786831 - Cell. 2000 Apr 14;101(2):119-22 – reference: 9655479 - Immunity. 1998 Jun;8(6):657-65 – reference: 11913069 - Nat Rev Immunol. 2002 Mar;2(3):185-94 – reference: 10951244 - J Invest Dermatol. 2000 Aug;115(2):260-6 – reference: 9523119 - Curr Opin Immunol. 1998 Feb;10(1):103-9 – reference: 17628800 - Cancer Immunol Immunother. 2008 Feb;57(2):165-74 – reference: 12747768 - Cancer Immun. 2001 Apr 27;1:7 – reference: 12903802 - Expert Rev Vaccines. 2003 Jun;2(3):369-79 – reference: 16931602 - J Leukoc Biol. 2007 Jan;81(1):15-27 – reference: 10839811 - J Exp Med. 2000 Jun 5;191(11):1965-74 – reference: 11884472 - J Immunol. 2002 Mar 15;168(6):2997-3003 – reference: 3458189 - Proc Natl Acad Sci U S A. 1986 May;83(10):3407-11 – reference: 9476895 - Cell. 1998 Feb 6;92(3):351-66 – reference: 11062489 - Nat Immunol. 2000 Nov;1(5):363-6 – reference: 19949080 - J Immunol. 2010 Jan 1;184(1):488-96 – reference: 12537755 - Int J Hyperthermia. 2002 Nov-Dec;18(6):563-75 – reference: 11861608 - Annu Rev Immunol. 2002;20:395-425 – reference: 12461080 - J Exp Med. 2002 Dec 2;196(11):1447-59 – reference: 11248808 - Nat Immunol. 2000 Aug;1(2):151-5 – reference: 17978282 - Ann N Y Acad Sci. 2007 Oct;1113:192-201 – reference: 8344253 - EMBO J. 1993 Aug;12(8):3143-51 – reference: 11576445 - Traffic. 2001 Oct;2(10):690-7 – reference: 10671216 - Eur J Immunol. 2000 Feb;30(2):594-603 – reference: 8376942 - J Exp Med. 1993 Oct 1;178(4):1391-6 – reference: 9334371 - J Exp Med. 1997 Oct 20;186(8):1315-22 – reference: 8122909 - Annu Rev Genet. 1993;27:437-96 – reference: 15958631 - Clin Cancer Res. 2005 Jun 15;11(12):4460-8 – reference: 8658133 - Science. 1996 Jun 14;272(5268):1606-14 |
| SSID | ssj0000561886 |
| Score | 2.0568187 |
| SecondaryResourceType | review_article |
| Snippet | Heat shock proteins (HSPs), the most important type of molecular chaperone, are expressed in all eukaryotic cells and have multiple functions, including the... |
| SourceID | pubmedcentral proquest pubmed crossref spandidos |
| SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 1543 |
| SubjectTerms | 20th century Animals Antigens Clinical trials Heat shock proteins Immune system Immunotherapy Metastasis molecular chaperone Oncology Peptides Studies Tumors vaccine Vaccines |
| Title | Tumor immunotherapy based on tumor-derived heat shock proteins (Review) |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/24260044 https://www.proquest.com/docview/1932646759 https://www.proquest.com/docview/1826578467 https://pubmed.ncbi.nlm.nih.gov/PMC3834116 |
| Volume | 6 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3rSwJBEF9KofoSvbOsLigoYst7eI9PUaFJoEQo-O2421lJsLvqNOi_b2ZvPROpr-6I68zOa2f2N4yd0XvPGsQBr4EE7tgDyQNMwvigDp6LyhVHajZgu-O2es5Tv97XF26Zbquc2kRlqCEVdEd-owIN1Op6cPv-wWlqFFVX9QiNZVYm6DI61V7fK-5YKDr21bBHPHYWp97DvPcdvbR1k1LlwbSvMeZx573SQqi52DG5ivqewBDS7Jc7am6wdR1HGne54DfZkky22EpbV8q32WN38pZ-GkN6_qEfWX0b5LLASBNjTIsc8PR94Qdkj43sFS2joWAbhklmXORFg8sd1ms2ug8trocmcIG-f8wlssl3a8KJYoXmBq4rfExLAg9iZ2BbwvYjfxC5mPn5UtgCTBl5dbAd24slYGq9y0pJmsh96nqKhTBrAWUlGFVhamMRQpcAC0QMplNhV1OmhUIjitNgi1GImQWxOExHIbE4JBZX2HlB_Z4jafxBV53yP9T6lIUz6VfYabGMmkDljSiR6QRpMFNC-4NUFbaXi6v4IUsB8Tu4ZW9OkAUBoWzPryTDV4W2jSm8Y9K2TgqRz741Ul1jLsdA1D74f-OHbI3-Y94KU2Wl8edEHmFAM46P1ak9ZuX7Ruf55Qf1GvSt |
| linkProvider | ProQuest |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1LT9tAEB4BlaCXqi3QpqVlkYoEQts4XsePQ1VVBRoK4RSk3Iy9sxGRgg04acWf6m_szPoBEYIb1-zE2czO4xvP7AzAF77v6WAaSQcNSk-NjIwoCJOjLgY-KVea2NmA_VO_d-b9HnaHC_CvvgvDZZW1TbSGGnPN78jbFmiQVnej71fXkqdGcXa1HqFRisWxuf1LIVvx7WifznfbdQ8PBj97spoqIDU5x6k09JzQd7SXpLbdGfq-Dgm3RwGm3ki5WoVJOEp8Co1Co5XGjkmCLipPBalBij3puYvwghyvw8FeMAyadzqMxkM7XJLE3JVc61jW2hMqcNs5Zzo66ithLH_eCz6Atg8rNFfIvmQ4xry45_4OX8OrCreKH6WgvYEFk72F5X6VmV-FX4PZZX4jxnzdpLrUdSvYRaLIMzHlRYkk7X_oA7b_orggSyxsm4hxVoidMkmxuwZnz8LOdVjK8sy85yqrVOuOE3EURCiOQimXO4JpdFGn2PFasFczLdZVB3MepDGJKZJhFsf5JGYWx8ziFmw31Fdl545H6DZq_seV_hbxnbS1YKtZJs3jdEqSmXxGNBSZkb0jqha8K4-r-SHXNv73aMvB3EE2BNzVe34lG1_Y7t4qJGDB29psjvzuWxNbpeZLAr7qw9Mb34SV3qB_Ep8cnR5_hJf8f8synA1Ymt7MzCcCU9P0s5VgAefPrTL_AXfxMDk |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1LT9tAEB7RINFeEH3RFChbqUitqiWJ1_HjgKpSSKGUCFUgcTP2zlpESm3ACYi_1l_XmfUDItTeuGYnzmZ2Ht94ZmcAPvB9zy4moeyiQemq1MiQgjCZ9tH3SLmS2M4GPBx6eyfuj9P-6Rz8qe_CcFllbROtocZc8zvyjgUapNX9sJNWZRFHO4MvF5eSJ0hxprUep1GKyIG5vaHwrdja36Gz3nCcwe7xtz1ZTRiQmhzlRBp6ZuB1tRsntvUZep4OCMOHPiZuqhytgjhIY4_CpMBopbFnYr-PylV-YpDiUHruE5j3OSpqwfz27vDoV_OGh7F5YEdNktA7kisfy8p7wghOJ-e8R09tEuLyZn3iA6D7sF7zKVmbDEeYF_ec4WAJFisUK76WYvcc5kz2AhYOqzz9S_h-PP2dX4kRXz6prnjdCnaYKPJMTHhRIsn-NX3A3kAU52SXhW0aMcoK8bFMWXx6BSePwtDX0MryzLzhmqtE61435JiIMB0FVg73B9PooE6w57bhc820SFf9zHmsxjiiuIZZHOXjiFkcMYvbsNFQX5R9PP5Bt1rzP6q0uYjuZK8N75tl0kNOrsSZyadEQ3EaWT-iasNyeVzNDzl2DIBLW_ZnDrIh4B7fsyvZ6Nz2-lYBwQze1npz5HffGtuaNU8SDFZv_7_xdVggdYl-7g8PVuAZ_92yJmcVWpOrqVkjZDVJ3lUiLODssbXmL9QJNdQ |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Tumor+immunotherapy+based+on+tumor-derived+heat+shock+proteins+%28Review%29&rft.jtitle=Oncology+letters&rft.au=ZHANG%2C+YUNFEI&rft.au=ZHENG%2C+LIANHE&rft.date=2013-12-01&rft.issn=1792-1074&rft.eissn=1792-1082&rft.volume=6&rft.issue=6&rft.spage=1543&rft.epage=1549&rft_id=info:doi/10.3892%2Fol.2013.1616&rft.externalDBID=n%2Fa&rft.externalDocID=10_3892_ol_2013_1616 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1792-1074&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1792-1074&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1792-1074&client=summon |